1-5 of 5
Chris Materna
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Renew Trial in Progress: A Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Neoplasms (MDS)

Rami S. Komrokji, Maria Diez-Campelo, Lynette C.Y. Chee, Thomas Cluzeau, Amy E. DeZern, Pierre Fenaux, Guillermo Garcia-Manero, Aristoteles Giagounidis, Uwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini, Mikkael A. Sekeres, Amer M. Zeidan, Rena Buckstein, Miranda Ross, Ying Jiang, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 3228.1.
https://doi.org/10.1182/blood-2024-200797
Published: 2024
Journal Articles

Hematological Improvement and Other Clinical Benefits of Elritercept As Monotherapy and in Combination with Ruxolitinib in Participants with Myelofibrosis from the Ongoing Phase 2 Restore Trial

Claire Harrison, Lynette C.Y. Chee, Timothy Devos, Maria Laura Fox, Alessandra Iurlo, Francesca Palandri, David M Ross, Shuhying Tan, Alessandro Maria Vannucchi, Marielle Wondergem, Michael Pace, Hongying Wang, Ming Yang, Ying Jiang, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 997.
https://doi.org/10.1182/blood-2024-201729
Published: 2024
Journal Articles

Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)

Aristoteles Giagounidis, Monteserrat Arnan, Lynette C.Y. Chee, Thomas Cluzeau, Maria Diez-Campelo, Devendra Hiwase, David M Ross, Mikkael A. Sekeres, Shuhying Tan, David Valcarcel, Rena Buckstein, Bhavna Patel-Shah, Ming Yang, Ying Jiang, Jiani Yin, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 1825.
https://doi.org/10.1182/blood-2024-203274
Published: 2024
Journal Articles

Hematologic Improvement and Fatigue Reduction with Elritercept (KER-050) in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS) with Non-Transfusion Dependent Anemia: New Analyses from an Ongoing Phase 2 Trial

Shuhying Tan, Montserrat Arnan, Lynette C.Y. Chee, Thomas Cluzeau, Maria Diez-Campelo, Aristoteles Giagounidis, Devendra Hiwase, David M Ross, Mikkael A. Sekeres, David Valcarcel, Bhavna Patel-Shah, Ming Yang, Ying Jiang, Jiani Yin, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 4591.
https://doi.org/10.1182/blood-2024-208186
Published: 2024
Journal Articles

Rker-050, a Novel Activin Receptor Type II Ligand Trap, Rescued Anemia and Reduced Bone Loss in a Mouse Model of Myelodysplastic Syndromes

Blake S Moses, Chris Materna, Remya Nathan, Tandicka Nurse, Keith Babbs, Claire Tseng, Ffolliott Fisher, Jasbir Seehra, Jenn Lachey
Journal: Blood
Blood (2022) 140 (Supplement 1): 9763–9764.
https://doi.org/10.1182/blood-2022-169360
Published: 2022